[(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

C43H58N4O10 — CID 144991809

IUPAC[(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)C[C@@H](C)C[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
InChIInChI=1S/C43H58N4O10/c1-23-12-11-13-25(3)42(53)45-35-30(22-44-47-17-15-46(9)16-18-47)37(50)32-33(38(35)51)36(49)28(6)40-34(32)41(52)43(8,57-40)55-19-14-31(54-10)27(5)39(56-29(7)48)26(4)21-24(2)20-23/h11-14,19,22-24,26-27,31,39,49-51H,15-18,20-21H2,1-10H3,(H,45,53)/b12-11+,19-14+,25-13-,44-22+/t23-,24+,26+,27+,31-,39-,43-/m0/s1
InChIKeyYCLVITKBRKFFJV-ONMKMRHDSA-N
MW790.95 g/mol
LogP6.39
Rot. Bonds4

About [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

[(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (PubChem CID 144991809) has the molecular formula C43H58N4O10 and a molecular weight of 790.95 g/mol. Its IUPAC name is [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.

Molecular Properties

Compound Name[(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
PubChem CID144991809
Molecular FormulaC43H58N4O10
Molecular Weight790.95 g/mol
Exact Mass790.42
IUPAC Name[(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)C[C@@H](C)C[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
InChIInChI=1S/C43H58N4O10/c1-23-12-11-13-25(3)42(53)45-35-30(22-44-47-17-15-46(9)16-18-47)37(50)32-33(38(35)51)36(49)28(6)40-34(32)41(52)43(8,57-40)55-19-14-31(54-10)27(5)39(56-29(7)48)26(4)21-24(2)20-23/h11-14,19,22-24,26-27,31,39,49-51H,15-18,20-21H2,1-10H3,(H,45,53)/b12-11+,19-14+,25-13-,44-22+/t23-,24+,26+,27+,31-,39-,43-/m0/s1
InChIKeyYCLVITKBRKFFJV-ONMKMRHDSA-N
XLogP6.39
TPSA179.69 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds4
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500790.95
LogP ≤ 56.39
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hzone_phenol_A(479)', 'substructure': 'N/A'}, {'alert_name': 'hzone_pipzn(79)', 'substructure': 'N/A'}, {'alert_name': 'keto_naphthol_A(2)', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}, {'alert_name': 'hydroquinone', 'substructure': 'N/A'}

Analyze [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The IUPAC name of [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (CID 144991809) is [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.
What is the SMILES notation for [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The canonical SMILES for [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)C[C@@H](C)C[C@@H](C)[C@H](OC(C)=O)[C@@H]1C.
What is the InChIKey of [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The InChIKey is YCLVITKBRKFFJV-ONMKMRHDSA-N. The full InChI is InChI=1S/C43H58N4O10/c1-23-12-11-13-25(3)42(53)45-35-30(22-44-47-17-15-46(9)16-18-47)37(50)32-33(38(35)51)36(49)28(6)40-34(32)41(52)43(8,57-40)55-19-14-31(54-10)27(5)39(56-29(7)48)26(4)21-24(2)20-23/h11-14,19,22-24,26-27,31,39,49-51H,15-18,20-21H2,1-10H3,(H,45,53)/b12-11+,19-14+,25-13-,44-22+/t23-,24+,26+,27+,31-,39-,43-/m0/s1.
What are the key properties of [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
[(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate has a molecular weight of 790.95 g/mol, XLogP of 6.39, 4 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for [(7S,9E,11S,12R,13S,14R,16R,18R,19E,21Z)-2,27,29-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is sourced from PubChem (CID 144991809), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).